Improved Drug Adherence in Patients with Chronic Myeloid Leukemia in the Chronic Phase by Switching to Second-Generation Tyrosine Kinase Inhibitors.
about
Improved Drug Adherence in Patients with Chronic Myeloid Leukemia in the Chronic Phase by Switching to Second-Generation Tyrosine Kinase Inhibitors.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Improved Drug Adherence in Pat ...... on Tyrosine Kinase Inhibitors.
@en
Improved Drug Adherence in Pat ...... on Tyrosine Kinase Inhibitors.
@nl
type
label
Improved Drug Adherence in Pat ...... on Tyrosine Kinase Inhibitors.
@en
Improved Drug Adherence in Pat ...... on Tyrosine Kinase Inhibitors.
@nl
prefLabel
Improved Drug Adherence in Pat ...... on Tyrosine Kinase Inhibitors.
@en
Improved Drug Adherence in Pat ...... on Tyrosine Kinase Inhibitors.
@nl
P2093
P2860
P356
P1433
P1476
Improved Drug Adherence in Pat ...... on Tyrosine Kinase Inhibitors.
@en
P2093
Akiko Konishi
Atsushi Okamoto
Kenta Yamamoto
Shin-Ichiro Kawaguchi
Terufumi Yamaguchi
Yasuhiro Maeda
Yoshitaka Kanai
P2860
P304
P356
10.1159/000477893
P577
2017-09-05T00:00:00Z